7 August 2021 - Issue previously raised in Trump administration.
The Health and Human Services Department on Friday proposed to withdraw a Trump-era drug payment model tying U.S. costs to foreign prices.
The agency didn’t rule out releasing its own policy for cutting down skyrocketing medicine costs.